The visual scoring of sleep in adults.
Michael H Silber, Sonia Ancoli-Israel, Michael H Bonnet...
https://pubmed.ncbi.nlm.nih.gov/17557422/Actively Recruiting
Led by Jakub Antczak · Updated on 2024-10-15
90
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating the effects of newer forms of transcranial magnetic stimulation called intermittent theta-burst stimulation iTBS and continuous theta-burst stimulation cTBS on symptoms of depression, including insomnia, daytime sleepiness, and fatigue. This study focuses on adults with major or bipolar depression who experience sleep problems and fatigue, aiming to assess how these treatments impact these specific symptoms. The study will also evaluate safety and therapeutic potential, supported by the lead investigator Jakub Antczak. Participants will receive either active iTBS over the left dorsolateral prefrontal cortex DLPFC, active cTBS over the right DLPFC, or sham stimulation as a placebo. Treatment consists of 90 sessions over 20 consecutive working days four weeks, with three sessions per day. Each iTBS session delivers 900 magnetic pulses, while each cTBS session delivers 1200 pulses. Sham stimulation mimics these procedures without active pulses. Throughout the study, participants will be assessed before treatment and four weeks after finishing intervention using measures such as the Beck Depression Inventory 2 and Pittsburgh Sleep Quality Index to track mood and sleep quality. Secondary assessments include scales for sleepiness, fatigue, psychiatric symptoms, and quality of life. Sleep stages will be monitored over approximately one year to observe longer-term effects. The study uses a randomized, triple-masked design and lasts from May 2024 to May 2027.
CONDITIONS
Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
B
Bogdan Stefanowski, MD
J
Jakub Antczak, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jakub Antczak
Lead Sponsor
Institute of Psychiatry and Neurology, Warsaw
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive active or sham intermittent or continuous theta burst stimulation over the dorsolateral prefrontal cortex. Therapy includes 90 sessions over 20 consecutive working days (four weeks), with three sessions per day.
Multiple visits, three sessions daily over 20 working days
Duration - 4 weeks
Participants are monitored for safety and therapeutic effects on sleep quality, sleep propensity, fatigue, and daytime sleepiness after completing the stimulation sessions.
1 to 2 visits after treatment completion
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Michael H Silber, Sonia Ancoli-Israel, Michael H Bonnet...
https://pubmed.ncbi.nlm.nih.gov/17557422/Jakub Antczak
Lead Sponsor
Institute of Psychiatry and Neurology, Warsaw
Collaborating Sponsor